INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 44h ago
HOUSE PTR4h ago
SEC 13F4h ago
ROBINHOOD CHAIN4h ago
SEC FORM 4/Open-market saleVerified dataRule 10b5-1 plan

Adamson Philip B. sold CVRX

Chief Medical Officer · CVRx, Inc. · Common Stock

Side
SELL
Value
$9,973
Shares
1,262
Price
$7.9
Executed
Mar 2, 2026
Disclosed
Mar 16, 2026
Disclosure timeline14 days from execution to publication · legal deadline 2 business days
Mar 2 executedMar 16, 2026 disclosed

CVRX · daily

Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.

Insider Score

Experimental signal
15/ 100 · ROUTINE
Methodology →
  • Transaction type+6 / 20

    Open-market sale

  • Relative size+1 / 25

    $10K reported value · 2.0% of prior position

  • Filing timing+10 / 15

    Disclosed 10 business days after execution (deadline: 2)

  • Historical behavior+8 / 15

    First recorded trade by this actor in this security

  • Frequency & clustering0 / 15

    No clustered activity in the dataset

  • Market events0 / 10

    No material company filing within 60 days after the trade

  • Pre-arranged plan-10

    Executed under a Rule 10b5-1 trading plan

    • The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.

    Other disclosed activity · CVRX

    ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
    51
    BB
    Binkowski BrentCHIEF OPERATING OFFICER
    CVRXCVRx, Inc.
    Open-market purchase
    		BUY$76K
    26.2K sh
    		Aug 13, 2026Aug 13, 2026
    traded Aug 13, 2026
    		+0dSEC FORM 4

    Evidence

    5
    BB
    Binkowski BrentCHIEF OPERATING OFFICER
    CVRXCVRx, Inc.
    Open-market sale · 10b5-1 plan
    		SELL$3,338
    1,309 sh
    		Aug 12, 2026Aug 13, 2026
    traded Aug 12, 2026
    		+1dSEC FORM 4

    Evidence

    21
    AB
    Adamson Philip B.Chief Medical Officer
    CVRXCVRx, Inc.
    Grant or award · 10b5-1 plan
    		A—
    41.0K sh
    		Feb 27, 2026Mar 16, 2026
    traded Feb 27, 2026
    		+17dSEC FORM 4

    Evidence

    9
    AB
    Adamson Philip B.Chief Medical Officer
    CVRXCVRx, Inc.
    Grant or award · 10b5-1 plan
    		A—
    62.0K sh
    		Feb 27, 2026Mar 16, 2026
    traded Feb 27, 2026
    		+17dSEC FORM 4

    Evidence

    Evidence

    Verified data

    Read directly from the primary public document; every field below is as reported by the filer.

    Source

    Document
    SEC Form 4
    Publisher
    U.S. Securities and Exchange Commission (EDGAR)
    Document ID
    0002056191-26-000004
    Machine-readable
    Structured copy

    Timestamps

    Event (reported)
    Mar 2, 2026
    Published
    Mar 16, 2026
    Ingested by INSIDER
    Nov 5, 04:11 UTC
    Last re-read
    Nov 5, 04:11 UTC

    Extracted facts

    Filer
    Adamson Philip B.
    Role
    Chief Medical Officer
    Transaction
    Open-market saleAs filed: “S”
    Asset
    CVRx, Inc.
    Ticker
    CVRX
    Shares
    1,262
    Price per share
    $7.9
    Value
    $9,973
    Execution date (reported)
    Mar 2, 2026
    Owned after transaction
    61.6K shares
    Rule 10b5-1 plan
    Yes, as checked by the filer
    Days from execution to publication
    14

    Calculation

    Value = shares × reported price per share

    • Shares: 1,262
    • Price: $7.9027

    = $9,973

    What this establishes

    Adamson Philip B. filed this Form 4 reporting a open-market sale of CVRX on Mar 2, 2026. It became public on Mar 16, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.

    Extraction

    Method
    Form 4 XML
    Confidence
    1.00
    Chief Medical Officer
    Adamson Philip B.cik:0002056191
    Issuer
    CVRx, Inc.cik:0001235912

    Revision history · 0

    No field has changed since this record was first ingested.

    Company events

    No records

    No material filings recorded for this issuer.